As our streptavidin-drug conjugates were generated in-house with accessible tools readily, reagents, and routine molecular biology techniques, we anticipate this flexible platform will facilitate the marketing and evaluation of ADCs for myriad targeting applications
As our streptavidin-drug conjugates were generated in-house with accessible tools readily, reagents, and routine molecular biology techniques, we anticipate this flexible platform will facilitate the marketing and evaluation of ADCs for myriad targeting applications. Keywords: Antibody-drug conjugate, streptavidin, HSCT, leukemia INTRODUCTION Hematopoietic stem cell transplantation (HSCT) PRDI-BF1 is definitely a lifesaving therapy which gives the…